News

Roche expands the Global Access Program beyond HIV; to include tests for MTB, Hepatitis, Human Papillomavirus

The Global Access Program is expanding beyond HIV, to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for low and middle income country programs

Read More

Jul 23, 2019

By : Team ABLE

Tricog named Top Innovator at ET Startup Awards 2019; Niramai, StellApps, Zumutor were key contenders

It is believed that the jury took note of the critical use of technology and its requirement and relevance in a country like India.

Read More

Jul 22, 2019

By : Team ABLE

Ministry of Health and Ministry of AYUSH ink collaboration for Tuberculosis Free India Initiative

The intended collaboration between the two Ministries aims at development of linkages and integration of TB care services within the infrastructure and institutional network of AYUSH.

Read More

Jul 19, 2019

By : Team ABLE

Merck and Broad Institute sign CRISPR license framework to encourage innovation

Under the agreement, companies applying CRISPR in their research and development activities can license both sets of IP through Broad Institute.

Read More

Jul 19, 2019

By : Team ABLE

Boehringer Ingelheim collaborates with Bridge Biotherapeutics to expand Idiopathic Pulmonary Fibrosis pipeline

Boehringer Ingelheim has entered into a collaboration and global license agreement for Bridge Biotherapeutics’sautotaxin inhibitor BBT-877 to be developed for fibrosing interstitial lung diseases including IPF

Read More

Jul 19, 2019

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights